CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 440 enrolled
Drug / intervention
Placebo +2 moredrug
Likely dose
Avanafil 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01698684
NCT01698684Phase 4Completed
CompareCT.gov

A Randomized, Double-Blind, Placebo-Controlled Evaluation of Avanafil for On-Demand Treatment of Men With Erectile Dysfunction

VIVUS LLC·interventional·Posted Oct 3, 2012·Updated Oct 27, 2014

In Brief

A Phase 4 clinical trial evaluating Placebo, Avanafil 100 mg, and 1 other intervention for Erectile Dysfunction. Completed, enrolled 440 participants across 3 sites.

Detailed Summary

The objectives of this study are to examine the therapeutic effects of two doses of avanafil after dosing in men with erectile dysfunction

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 3, 2012
Enrollment StartSep 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.7 years ago

Interventions

Placebodrug

One dose 15 minutes before attempting intercourse

Avanafil 100 mgdrug

One dose 15 minutes before attempting intercourse

Avanafil 200 mgdrug

One dose 15 minutes before attempting intercourse